A case of cyclophosphamide-induced posterior reversible encephalopathy syndrome: Is it dose-related side effect?


Article PDF :

Veiw Full Text PDF

Article type :

Case Report

Author :

Theeb Osama Sulaiman, Ahmed K A Yasin, Abdellatif Ismail

Volume :

1

Issue :

2

Abstract :

We reported a case of cyclophosphamide (CYP)-induced posterior reversible encephalopathy syndrome (PRES) in a 26-year-old previously healthy male patient who was presented to the emergency department with a history of fever, shortness of breath, and hemoptysis. After extensive investigations, including bronchoscopy and autoimmune screening, he was diagnosed with renal-pulmonary syndrome. The diagnosis of CYP-related PRES was based on the development of neurological clinical picture supported by magnetic resonance imaging findings. The dose of CYP was decreased to 75 mg/day, and the patient’s symptoms improved after 3 days.

Keyword :

  Antineutrophil cytoplasmic antibody, Cyclophosphamide, Posterior reversible encephalopathy syndrome, Renal-pulmonary disease
Journals Insights Open Access Journal Filmy Knowledge Hanuman Devotee Avtarit Wiki In Hindi Multiple Choice GK